Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoyuki Maeda

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
Molecular Cancer Therapeutics|August 10, 2019
U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal CancerShigehiro Koganemaru, Yasutoshi Kuboki, Yoshikatsu Koga, et al.
Transplantation|February 18, 2004
Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surfaceKohji Nishida, Masayuki Yamato, Yasutaka Hayashida, et al.
Investigative Ophthalmology & Visual Science|January 25, 2006
Transplantation of tissue-engineered epithelial cell sheets after excimer laser photoablation reduces postoperative corneal hazeYasutaka Hayashida, Kohji Nishida, Masayuki Yamato, et al.
Oncotarget|September 10, 2019
DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft modelTakeshi Jimbo, Mana Hatanaka, Takahiro Komatsu, et al.
Journal of Cataract and Refractive Surgery|May 24, 2008
Corneal ablation with new 193 nm solid-state laser: preliminary experimentsTomoya Nakagawa, Naoyuki Maeda, Osman Cekic, et al.
Journal of Cataract and Refractive Surgery|November 14, 2008
Characteristics of ocular higher-order aberrations in patients with pellucid marginal corneal degenerationYoshinori Oie, Naoyuki Maeda, Ryo Kosaki, et al.
Acta Histochemica|October 21, 2022
The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophyTomohito Iwasaki, Jessica R Terrill, Kei Kawarai, et al.
Ophthalmology|March 5, 2013
Classification of secondary corneal amyloidosis and involvement of lactoferrinKaoru Araki-Sasaki, Koji Hirano, Yasuhiro Osakabe, et al.
Oncogene|October 11, 2018
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLCKimio Yonesaka, Naoki Takegawa, Satomi Watanabe, et al.
The New England Journal of Medicine|September 17, 2004
Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epitheliumKohji Nishida, Masayuki Yamato, Yasutaka Hayashida, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
Molecular Cancer Therapeutics|August 10, 2019
U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal CancerShigehiro Koganemaru, Yasutoshi Kuboki, Yoshikatsu Koga, et al.
Transplantation|February 18, 2004
Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surfaceKohji Nishida, Masayuki Yamato, Yasutaka Hayashida, et al.
Investigative Ophthalmology & Visual Science|January 25, 2006
Transplantation of tissue-engineered epithelial cell sheets after excimer laser photoablation reduces postoperative corneal hazeYasutaka Hayashida, Kohji Nishida, Masayuki Yamato, et al.
Oncotarget|September 10, 2019
DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft modelTakeshi Jimbo, Mana Hatanaka, Takahiro Komatsu, et al.
Journal of Cataract and Refractive Surgery|May 24, 2008
Corneal ablation with new 193 nm solid-state laser: preliminary experimentsTomoya Nakagawa, Naoyuki Maeda, Osman Cekic, et al.
Journal of Cataract and Refractive Surgery|November 14, 2008
Characteristics of ocular higher-order aberrations in patients with pellucid marginal corneal degenerationYoshinori Oie, Naoyuki Maeda, Ryo Kosaki, et al.
Acta Histochemica|October 21, 2022
The location of protein oxidation in dystrophic skeletal muscle from the mdx mouse model of Duchenne muscular dystrophyTomohito Iwasaki, Jessica R Terrill, Kei Kawarai, et al.
Ophthalmology|March 5, 2013
Classification of secondary corneal amyloidosis and involvement of lactoferrinKaoru Araki-Sasaki, Koji Hirano, Yasuhiro Osakabe, et al.
Oncogene|October 11, 2018
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLCKimio Yonesaka, Naoki Takegawa, Satomi Watanabe, et al.
The New England Journal of Medicine|September 17, 2004
Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epitheliumKohji Nishida, Masayuki Yamato, Yasutaka Hayashida, et al.
Pageof 24